Clik here to view.
Clik here to view.
Parse Biosciences推出Trailmaker数据分析平台以简化单细胞测序
西雅图 (美国商业资讯)– Parse Biosciences是领先的易访问和可扩展单细胞测序解决方案提供商，今天宣布该公司专为单细胞数据分析而构建的用户友好型云平台Trailmaker™正式上线。Trailmaker具有快速、可扩展的特点，可提供端到端的分析，消除了常见的分析壁垒，可快速将单细胞数据转换为生物学见解。...
View ArticleClik here to view.
Morinaga Milk的新研究突破证明了其人源双歧杆菌（HRB）菌株在代谢肠道毒素前体方面的优越性
东京 (美国商业资讯)– 日本领先的乳制品公司Morinaga Milk Industry Co.,...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the...
View ArticleClik here to view.
Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer...
SAN DIEGO Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for...
View ArticleClik here to view.
Bionova Scientific, U.S. biologics CDMO of the Asahi Kasei Group, to...
TOKYO & NEW YORK & DÜSSELDORF, Germany Asahi Kasei Medical’s U.S. subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new business line providing services...
View ArticleClik here to view.
Bio-Sourcing与Afrigen Biologics合作开发突破性生物制造平台以改善南非生物治疗药物的可及性
列日，比利时 (美国商业资讯)– 比利时生物技术公司Bio-Sourcing今天宣布与南非生物技术公司Afrigen Biologics签订合作协议，在南非开发突破性生物治疗平台BioMilk™的试点项目。 Bio-Sourcing的尖端平台有望重新定义医疗解决方案的格局。BioMilk是新型疗法开发领域的重大飞跃，旨在解决全球未满足的医疗需求，并根本改善单克隆抗体 (mAbs)...
View ArticleClik here to view.
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by...
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the U.S. Food and Drug...
View ArticleClik here to view.
C3i Center Inc是加拿大首家获得药品经营许可的委托开发制造商，可商业化生产细胞疗法药物产品
蒙特利尔 (美国商业资讯)– C3i Center Inc (C3i) 宣布已获监管部门批准药品经营许可（DEL），可进行细胞疗法的商业化生产，从而使C3i成为加拿大首家达到这一里程碑的委托开发制造商。 在经加拿大卫生部细胞和基因治疗专家检验合格之后，C3i获批DEL，这是对该公司在专业知识、监管技术和严格质量标准方面的行业领先地位的认可。 C3i首席执行官Louisa...
View ArticleClik here to view.
Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform
BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully...
View ArticleClik here to view.
C3iセンター、カナダ初のCDMOとして細胞治療薬の商業生産に向けた医薬品製造業の許可を取得
モントリオール （ビジネスワイヤ） — C3iセンター（C3i）は、細胞療法の商業生産のために医薬品製造許可（DEL）の形で規制当局の承認を取得したことを発表しました。これにより、C3iはカナダでこのマイルストーンを達成した最初のCDMOとなりました。...
View ArticleClik here to view.
Silence Therapeutics Achieves $2 Million Research Milestone Payment from...
LONDON Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming peoples’ lives by silencing diseases through...
View ArticleClik here to view.
RoslinCT、ピーター・マティソン教授とアレクサンダー・ヴォス氏を新たに非業務執行取締役に任命
スコットランド、エディンバラ＆ボストン （ビジネスワイヤ） — 細胞・遺伝子治療開発製造受託機関（CDMO）の優良企業であるRoslinCTは、ピーター・マティソン教授（名誉MB BS、PhD、FRCP、FRCPE、FMedSci、FRSE、FRSA）とアレクサンダー・ヴォス氏を新たに非業務執行取締役に任命したことをお知らせいたします。...
View ArticleClik here to view.
RoslinCT任命Peter Mathieson爵士教授和Alexander Vos为新的非执行董事
苏格兰爱丁堡和波士顿 (美国商业资讯)– 领先的细胞和基因治疗合同开发和制造组织(CDMO) RoslinCT欣然宣布，任命Peter Mathieson MB BS (Hons), PhD, FRCP, FRCPE, FMedSci, FRSE, FRSA爵士教授和Alexander Vos为新的非执行董事。 Peter...
View ArticleClik here to view.
ENCell Presents the Phase 1 Clinical Trial Results of their Mesenchymal Stem...
SEOUL, South Korea ENCell Co., Ltd., a biotech in South Korea specializing in Cell and Gene therapy (CGT), presented promising results from their First-in-Human Phase 1 clinical trial of the novel...
View ArticleClik here to view.
Genexine Announces Merger with EPD Biotherapeutics to Strengthen Drug...
SEOUL, South Korea Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of...
View ArticleClik here to view.
Propanc Biopharma’s CSO Predicts PRP Could Solve Problem That Impacts...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Shionogi Provides Updates on Zatolmilast, an Investigational Drug for Fragile...
OSAKA, Japan Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced progress on the development program for...
View ArticleClik here to view.
JCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552: Chairman and President Shin Ashida, “JCR”) announced presentations highlighting its latest advancements in gene therapy research at the 7th...
View ArticleClik here to view.
Boston Oncology和King Fahd Medical City（KFMC）合作在沙特阿拉伯推进本地化细胞与基因疗法
马萨诸塞州坎布里奇和沙特阿拉伯利雅得 (美国商业资讯)– 根据旨在实现沙特阿拉伯王国医疗保健转型的重要倡议，Boston Oncology和King Fahd Medical City (KFMC) 签署了就细胞和基因疗法开展本地化合作的意向书。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View Article